Inhibitory Effects of the Polyphenols from the Root of Rhizophora apiculata Blume on Fatty Acid Synthase Activity and Human Colon Cancer Cells

• Published in: Molecules (Basel, Switzerland) Switzerland), 2024-03, Vol.29 (5), p.1180
• Main Authors: Liang, Yan, Ban, Yue, Liu, Lei, Li, Yanchun
• Format: Article
• Language: English
• Subjects: Binding sites; Cancer therapies; Colonic Neoplasms; Colorectal cancer; fatty acid synthase; Fatty Acid Synthases - metabolism; Fatty Acids; human colon cancer; Humans; inhibitor; Obesity; polyphenol; Polyphenols; Rhizophora apiculata Blume; Rhizophoraceae; Weight control; β-ketoacyl reductase
• ISSN: 1420-3049; 1420-3049
• DOI: 10.3390/molecules29051180

Marine mangrove vegetation has been traditionally employed in folk medicine to address various ailments. Notably, Blume has exhibited noteworthy properties, demonstrating efficacy against cancer, viruses, and bacteria. The enzyme fatty acid synthase (FAS) plays a pivotal role in de novo fatty acid synthesis, making it a promising target for combating colon cancer. Our study focused on evaluating the FAS inhibitory effects of both the crude extract and three isolated compounds from . The n-butanol fraction of extract (BFR) demonstrated a significant inhibition of FAS, with an IC value of 93.0 µg/mL. For inhibition via lyoniresinol-3α- -β-rhamnopyranoside (LR), the corresponding IC value was 20.1 µg/mL (35.5 µM). LR competitively inhibited the FAS reaction with acetyl-CoA, noncompetitively with malonyl-CoA, and in a mixed manner with NADPH. Our results also suggest that both BFR and LR reversibly bind to the KR domain of FAS, hindering the reduction of saturated acyl groups in fatty acid synthesis. Furthermore, BFR and LR displayed time-dependent inhibition for FAS, with k values of 0.0045 min and 0.026 min , respectively. LR also exhibited time-dependent inhibition on the KR domain, with a k value of 0.019 min . In human colon cancer cells, LR demonstrated the ability to reduce viability and inhibit intracellular FAS activity. Notably, the effects of LR on human colon cancer cells could be reversed with the end product of FAS-catalyzed chemical reactions, affirming the specificity of LR on FAS. These findings underscore the potential of BFR and LR as potent FAS inhibitors, presenting novel avenues for the treatment of human colon cancer.